Multiple Sclerosis Clinical Trials in Colorado

19 recruiting studies across 2 cities

Browse by City

All Trials in Colorado

Phase

Trial	Phase	Sponsor	Dist.
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)	—	TG Therapeutics, Inc.	<1 mi
A Study to Evaluate the Safety, Tolerability, Efficacy, and Drug Levels of CC-97540 in Participants With Relapsing Forms of Multiple Sclerosis, Progressive Forms of Multiple Sclerosis or Refractory Myasthenia Gravis (MG) (Breakfree-2)	Phase 1	Juno Therapeutics, Inc., a Bristol-Myers Squibb Company	<1 mi
TSC Biosample Repository and Natural History Database	—	National Tuberous Sclerosis Association	<1 mi
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101	—	Kyverna Therapeutics	<1 mi
Efficacy and Safety Study of Frexalimab (SAR441344) in Adults With Nonrelapsing Secondary Progressive Multiple Sclerosis	Phase 3	Sanofi	8 mi
An Open-label Study of AZD0120 in Adults With Multiple Sclerosis	Phase 1	AstraZeneca	8 mi
Concentration of Ofatumumab in the Breast Milk of Lactating Women With Relapsing Forms of Multiple Sclerosis	Phase 4	Novartis Pharmaceuticals	8 mi
Study to Investigate Vagus Nerve Stimulation Paired With Motor Task for Remyelination and Functional Recovery	N/A	University of Colorado, Denver	8 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention Study	Phase 2	Darcy Krueger	8 mi
Efficacy and Safety Studies of Frexalimab (SAR441344) in Adults With Relapsing Forms of Multiple Sclerosis	Phase 3	Sanofi	8 mi
Care in Multiple Sclerosis (MS)	—	NYU Langone Health	8 mi
Blood Flow Restriction And Veterans With MS	N/A	VA Office of Research and Development	8 mi
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis Spasticity	Phase 2	Celgene	8 mi
Prospective Evaluation of Sequencing From antiCD-20 Therapies to Ozanimod	Phase 4	University of Colorado, Denver	8 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)	Phase 3	National Institute of Allergy and Infectious Diseases (NIAID)	8 mi
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)	—	Biogen	8 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses	Phase 2	Reunion Neuroscience Inc	8 mi
Home Based Infusions for Ocrelizumab	Phase 4	University of Colorado, Denver	13 mi
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENS	N/A	University of Colorado, Boulder	24 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.